ReviewFrontiers in oncology2026
Evidence summary on perioperative blood glucose management in liver cancer patients.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Systematically retrieve, evaluate, and synthesize the best available evidence on perioperative glycemic management in liver cancer patients to provide evidence-based guidance for clinical nursing practice. Methods: Using the "6S" evidence model, we conducted a top-down search of domestic and international databases, guideline portals, and professional association websites for best clinical practices, guidelines, systematic reviews, evidence summaries, expert consensus statements, and randomized controlled trials concerning perioperative glycemic management in hepatocellular carcinoma patients. The search period spanned January 2015 to December 2025. Selected literature underwent quality assessment, evidence extraction, and synthesis. Results: A total of 14 documents were included, comprising 4 guidelines, 1 systematic review, 1 evidence summary, 3 expert consensus statements, and 5 randomized controlled trials. This yielded 28 best evidence items across six domains: team-based perioperative glycemic management for liver cancer patients, preoperative assessment management, medication and nutritional management, blood glucose monitoring and targets, complication management, and health education. Conclusion: This study summarizes the best available evidence for perioperative glycemic management in patients with hepatocellular carcinoma, providing evidence-based guidance for healthcare professionals. Each piece of evidence should be thoroughly assessed for its appropriateness and feasibility before being translated and applied in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.